生物信息研究员
艾棣维欣(苏州)生物制药有限公司
- 公司规模:150-500人
- 公司性质:民营公司
- 公司行业:制药/生物工程
职位信息
- 发布日期:2021-06-03
- 工作地点:苏州-工业园区
- 招聘人数:1人
- 工作经验:3-4年经验
- 学历要求:硕士
- 语言要求:英语熟练
- 职位月薪:1.5-3万/月
- 职位类别:生物工程/生物制药
职位描述
岗位职责:
1. 基因、蛋白表达及结构优化等工作;
2. 基因,蛋白表达数据分析算法和流程开发, 编写基因优化相关生物信息软件及数据库;
3. 参与研发项目设计,负责基因表达、密码子优化等相关的设计及数据分析;
4.生物信息数据的采集、整理、挖掘和利用。
任职要求:
1.生物信息学以及相关专业硕士及以上学历;
2. 能顺利阅读、翻译英文科技文献;
3.能使用编程语言Perl, Python,C++,R等进行编程;
4.熟悉常用的生物网站(UCSC、NCBI、EBI、Essembl)
5. 主动性和责任心强,有良好的沟通能力和团队精神,良好的问题解决技巧、独立工作能力;
6. 有基因优化工作背景优先。
职能类别:生物工程/生物制药
公司介绍
艾棣维欣(苏州)生物制药有限公司位于苏州工业园区,是研发创新疫苗的生物技术公司。公司专注研究基因工程疫苗、DNA疫苗、新型疫苗佐剂技术,在国内外有系统的知识产权布局。
公司运用这些平台技术,主要进行抗病毒疫苗的研发,尤其在新型病毒性肺炎疫苗研发领域拥有国际先进技术实力。
艾棣维欣和美国INOVIO制药联合研发的新型冠状病毒DNA疫苗已在中美同步开展临床试验。艾棣维欣开发的新型呼吸道合胞病毒(RSV)肺炎疫苗正在海外开展临床研究,研发进展居于全球前列。
Advaccine Biopharmaceuticals Suzhou Co., Ltd. is a biotechnology company developing innovative vaccines in BioBay of Suzhou Industrial Park. The company focuses on the research of genetic engineering vaccine, DNA vaccine, innovative vaccine adjuvant technology. There is a systematic distribution of intellectual property in china and abroad.
The company uses these technologies, mainly engaged in the research and development of antiviral vaccines, especially the company’s innovated vaccine for viral pneumonia possesses the leading technology worldwide.
Clinical trials are being conducted for the COVID-19 DNA vaccine, co-developed by Advaccine and INOVIO Pharmaceuticals simultaneously in China and the United States. The company’s innovative vaccine for respiratory syncytial virus (RSV) is under clinical investigation abroad and its progress of research and development is in the forefront of the world.
公司运用这些平台技术,主要进行抗病毒疫苗的研发,尤其在新型病毒性肺炎疫苗研发领域拥有国际先进技术实力。
艾棣维欣和美国INOVIO制药联合研发的新型冠状病毒DNA疫苗已在中美同步开展临床试验。艾棣维欣开发的新型呼吸道合胞病毒(RSV)肺炎疫苗正在海外开展临床研究,研发进展居于全球前列。
Advaccine Biopharmaceuticals Suzhou Co., Ltd. is a biotechnology company developing innovative vaccines in BioBay of Suzhou Industrial Park. The company focuses on the research of genetic engineering vaccine, DNA vaccine, innovative vaccine adjuvant technology. There is a systematic distribution of intellectual property in china and abroad.
The company uses these technologies, mainly engaged in the research and development of antiviral vaccines, especially the company’s innovated vaccine for viral pneumonia possesses the leading technology worldwide.
Clinical trials are being conducted for the COVID-19 DNA vaccine, co-developed by Advaccine and INOVIO Pharmaceuticals simultaneously in China and the United States. The company’s innovative vaccine for respiratory syncytial virus (RSV) is under clinical investigation abroad and its progress of research and development is in the forefront of the world.
联系方式
- 公司地址:地址:span星湖街218号生物纳米园B1